These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12359753)

  • 1. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
    Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
    Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
    Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
    J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
    Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
    Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
    Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
    EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.
    Coin F; Bergmann E; Tremeau-Bravard A; Egly JM
    EMBO J; 1999 Mar; 18(5):1357-66. PubMed ID: 10064601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
    Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
    DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.
    Robles AI; Wang XW; Harris CC
    Oncogene; 1999 Aug; 18(33):4681-8. PubMed ID: 10467415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome.
    Araújo SJ; Nigg EA; Wood RD
    Mol Cell Biol; 2001 Apr; 21(7):2281-91. PubMed ID: 11259578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program.
    Xu Z; Chen ZP; Malapetsa A; Alaoui-Jamali M; Bergeron J; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Aloyz R; Panasci LC
    Anticancer Drugs; 2002 Jun; 13(5):511-9. PubMed ID: 12045463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAD2 interacts with DNA repair proteins and negatively regulates DNA damage repair.
    Fung MK; Han HY; Leung SC; Cheung HW; Cheung AL; Wong YC; Ling MT; Wang X
    J Mol Biol; 2008 Aug; 381(1):24-34. PubMed ID: 18597777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing alkylating agent resistance through ERCC2 gene transfection in human glioma cell line.
    Chen Z; Zhang J; Mohr G
    Chin Med J (Engl); 2003 Aug; 116(8):1171-4. PubMed ID: 12935404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
    Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
    Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein.
    Iyer N; Reagan MS; Wu KJ; Canagarajah B; Friedberg EC
    Biochemistry; 1996 Feb; 35(7):2157-67. PubMed ID: 8652557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality.
    de Boer J; Donker I; de Wit J; Hoeijmakers JH; Weeda G
    Cancer Res; 1998 Jan; 58(1):89-94. PubMed ID: 9426063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
    Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
    Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.